What is NDC 67877-732?

67877-732 is the product NDC for Lacosamide Oral Solution, Lacosamide 10 mg/mL solution, listed with the FDA by Ascend Laboratories, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Ascend Laboratories, LLC, NDC labeler code 67877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lacosamide Oral Solution?

7 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lacosamide Oral Solution NDC 67877-732

NDC codes

FDA NDC Directory

Product NDC (as listed)67877-732Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67877-0732Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
67877-732-95	67877073295	200 mL in 1 BOTTLE (67877-732-95)Marketed from May 20, 2022
67877-732-97	67877073297	465 mL in 1 BOTTLE (67877-732-97)Marketed from May 20, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lacosamide Oral Solution
Generic name (nonproprietary): lacosamide oral solution
Active ingredients: Lacosamide — 10 mg/mL
Dosage form: Solution
Route: Oral
Labeler: Ascend Laboratories, LLCNDC labeler code 67877
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214672
Marketing start: May 20, 2022
Listing expires: Dec 31, 2026
DEA schedule: CV
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 67877-732_c4d07291-0152-4092-a339-3edee132ef09SPL ID c4d07291-0152-4092-a339-3edee132ef09SPL set ID 4ae87834-05d8-43c8-aaa3-78047d4a573cRxCUI 993856UNII 563KS2PQY5UPC 0367877732954

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N467877073295 followed by a unit qualifier and the quantity

Package 67877-0732-95. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 9, 2025.

Indications (excerpt from the label)

Lacosamide oral solution is indicated for: Treatment of partial-onset seizures in patients 4 years of age and older ( 1.1 ) Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older ( 1.2 ) 1.1 Partial-Onset Seizures Lacosamide oral solution is indicated for the treatment of partial-onset seizures in patients 4 years of age and older. 1.2 Primary Generalized Tonic-Clonic Seizures Lacosamide oral solution is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older. Additional pediatric use information is approved for UCB, Inc.’s VIMPAT ® (lacosamide) oral solut…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 67877-732

What is NDC 67877-732?: 67877-732 is the product NDC for Lacosamide Oral Solution, Lacosamide 10 mg/mL solution, listed with the FDA by Ascend Laboratories, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lacosamide Oral Solution.
What is the active ingredient?: Lacosamide.
Who is the labeler?: Ascend Laboratories, LLC, NDC labeler code 67877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lacosamide Oral Solution?: 7 other product NDCs are listed under this name. See all Lacosamide Oral Solution NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lacosamide Oral Solution NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lacosamide Oral Solutionlacosamide	Lacosamide 10 mg/mL	SolutionOral	AvKARE	73190-103	73190-0103-20
Lacosamide Oral Solutionlacosamide oral	Lacosamide 10 mg/mL	SolutionOral	Florida Pharmaceutical Products, LLC	71921-411	71921-0411-71
Lacosamide Oral Solutionlacosamide	Lacosamide 10 mg/mL	SolutionOral	Kesin Pharmaceutical Corporation	81033-427	81033-0427-1481033-0427-1681033-0427-17+1 more
Lacosamide Oral Solutionlacosamide	Lacosamide 10 mg/mL	SolutionOral	Kesin Pharma Corporation	81033-428	81033-0428-02
Lacosamide Oral Solutionlacosamide	Lacosamide 10 mg/mL	SolutionOral	Ajenat Pharmaceuticals LLC	82983-427	82983-0427-31
Lacosamide Oral Solutionlacosamide	Lacosamide 10 mg/mL	SolutionOral	Chartwell RX, LLC	62135-885	62135-0885-2262135-0885-2362135-0885-24
Lacosamide Oral Solutionlacosamide	Lacosamide 10 mg/mL	SolutionOral	Chartwell Governmental & Specialty RX, LLC.	68999-885	68999-0885-2368999-0885-24